Exploring The Biology and Potential Drug Targets of ITPR3 (G3710)

Target Name: ITPR3

NCBI ID: G3710

ITPR3

Exploring The Biology and Potential Drug Targets of ITPR3

ITPR3 (InsP3R3) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is Insulin-like growth factor 3 receptor protein, and it is a member of the insulin-like growth factor 3 (IGF-3) family. This protein has been shown to play a role in various physiological processes in the body, including cell growth, differentiation, and survival.

Recent studies have suggested that ITPR3 may have potential as a drug target or biomarker. In this article, we will explore the biology and potential drug targets of ITPR3 in more detail.

biology and function

ITPR3 is a 21-kDa protein that is expressed in the brain, heart, and kidneys. It is a member of the Insulin-like growth factor 3 (IGF-3) family, which is a group of proteins that are involved in various physiological processes, including cell growth, differentiation, and survival. ITPR3 is characterized by a unique N-terminus that contains a farnesylated cysteine residue, which is known as a cysteine-rich region.

Several studies have shown that ITPR3 is involved in various physiological processes, including cell growth, differentiation, and survival. For example, ITPR3 has been shown to promote the growth and differentiation of various cell types, such as neurons and muscle cells. It has also been shown to play a role in the regulation of cellular stress, as well as in the regulation of inflammation and immune responses.

In addition to its role in physiology, ITPR3 has also been shown to be a potential drug target. Several studies have shown that ITPR3 can interact with various signaling pathways, including the TGF-β pathway. This suggests that ITPR3 may be a useful target for drugs that are designed to modulate these pathways. For example, several studies have shown that ITPR3 can be targeted with small molecules, such as inhibitors of the TGF-β pathway. These drugs have been shown to have a variety of therapeutic effects, including the treatment of various diseases, such as cancer and diabetes.

Potential drug targets

Several studies have suggested that ITPR3 may be a potential drug target for a variety of diseases. For example, ITPR3 has been shown to be involved in the regulation of cellular stress, which is a critical factor in the development of stress-related diseases, such as cancer, diabetes, and cardiovascular disease. It has also been shown to play a role in the regulation of inflammation and immune responses, which are also involved in the development of many diseases.

In addition to its potential role as a drug target, ITPR3 has also been suggested as a potential biomarker for the diagnosis and prognosis of various diseases. For example, studies have shown that ITPR3 can be expressed in a variety of tissues and cells, including cancer cells and immune cells. This suggests that ITPR3 may be a useful biomarker for the diagnosis and prognosis of various diseases.

Conclusion

In conclusion, ITPR3 is a protein that is involved in various physiological processes in the body, including cell growth, differentiation, and survival. Its unique N-terminus, which contains a cysteine-rich region, has led to its potential as a drug target or biomarker. Several studies have shown that ITPR3 can be targeted with small molecules, and it has been suggested as a potential drug target for the regulation of cellular stress, inflammation, and immune responses. Further research is needed to fully understand the biology and potential drug targets of ITPR3.

Protein Name: Inositol 1,4,5-trisphosphate Receptor Type 3

Functions: Receptor for inositol 1,4,5-trisphosphate, a second messenger that mediates the release of intracellular calcium (By similarity). Involved in cellular calcium ion homeostasis (PubMed:32949214)

The "ITPR3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ITPR3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets